Kevin Pfleger

Associate Professor

  • The University of Western Australia (M460), 35 Stirling Highway,

    6009 Perth


  • 2090 Citations
  • 23 h-Index
If you made any changes in Pure these will be visible here soon.

Personal profile


Professor Kevin Pfleger is Director of the WA Life Sciences Innovation Hub, Office of the Deputy Vice-Chancellor (Research), The University of Western Australia (UWA), as well as Head of Molecular Endocrinology and Pharmacology at the UWA Centre for Medical Research (Harry Perkins Institute of Medical Research). He is also Chief Scientific Advisor of Dimerix Limited, an ASX-listed spin-out company from UWA. Prof Pfleger was awarded his MA and PhD from Cambridge and Edinburgh Universities respectively, and relocated to Western Australia in October 2002. He was a National Health and Medical Research Council (NHMRC) Peter Doherty Research Fellow from 2005 to 2008, an Australian Research Council (ARC) Future Fellow from 2011 to 2014, and NHMRC RD Wright Fellow (Level 2) from 2015 to 2018.

Roles and responsibilities

Director, WA Life Sciences Innovation Hub

Head of Molecular Endocrinology and Pharmacology

Teaching Molecular Pharmacology of GPCRs and Molecular Neuroendocrinology

Chair of Accelerating Australia Executive Committee

Chair of the Scientific Advisory Committee of the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists (ASCEPT)

Member of the International Advisory Group of the British Pharmacological Society

Member of the WA Branch Committee of AusBiotech

Commercialisation Representative on the WAHTN Management Committee

Education/Academic qualification

Natural Sciences - Pharmacology, MA, University of Cambridge

Molecular Endocrinology and Pharmacology, PhD, University of Edinburgh

External positions

Chief Scientific Advisor, Dimerix Limited


  • Assay technology
  • Endocrinology—receptors
  • Molecular pharmacology
  • Protein interactions
  • Bioluminescence resonance energy transfer (BRET)
  • G protein-coupled receptors (GPCR)
  • Dimerisation
  • Heteromerisation
  • Arrestin

Fingerprint Fingerprint is based on mining the text of the person's scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 6 Similar Profiles
Energy Transfer Medicine & Life Sciences
G-Protein-Coupled Receptors Medicine & Life Sciences
Bioluminescence Chemical Compounds
Energy transfer Chemical Compounds
Ligands Medicine & Life Sciences
Proteins Medicine & Life Sciences
LHRH Receptors Medicine & Life Sciences
Chemokine Receptors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2002 2019

Transactivation of RAGE mediates angiotensin-induced inflammation and atherogenesis

Pickering, R., Tikellis, C., Rosado, C., Tsorotes, D., Dimitrropoulos, A., Smith, M., Huet, O., Bradley, R., Abhayawardana, R., Sargent, E., Golledge, J., Wang, Y., Jandeleit-Dahm, K., Cooper, M., Pfleger, K. & Thomas, M. C., 2 Jan 2019, In : The Journal of clinical investigation. 129, 1, CI99987.

Research output: Contribution to journalArticle

Transcriptional Activation
Angiotensin II
1 Citation (Scopus)

BRET-based assay to monitor EGFR transactivation by the AT1R reveals Gq/11 protein-independent activation and AT1R-EGFR complexes

O'Brien, S. L., Johnstone, E. K. M., Devost, D., Conroy, J., Reichelt, M. E., Purdue, B. W., Ayoub, M. A., Kawai, T., Inoue, A., Eguchi, S., Hébert, T. E., Pfleger, K. D. G. & Thomas, W. G., 1 Dec 2018, In : Biochemical Pharmacology. 158, p. 232-242 11 p.

Research output: Contribution to journalArticle

Gq-G11 GTP-Binding Protein alpha Subunits
Energy Transfer
Epidermal Growth Factor Receptor
Energy transfer

Experiential Training Courses for Medical Technology and Pharmaceutical Translation

Bradley, R. & Pfleger, K., 28 Nov 2018.

Research output: Contribution to conferencePoster

Pharmaceutical Technology
Biomedical Research
Organized Financing

Investigating microRNA-7 as a potential therapeutic in cancer

Horsham, J., 2018, (Unpublished)

Research output: ThesisDoctoral Thesis

Second Primary Neoplasms

Investigation of interactions between TLR2, MyD88 and TIRAP by bioluminescence resonance energy transfer is hampered by artefacts of protein overexpression

Sampaio, N. G., Kocan, M., Schofield, L., Pfleger, K. D. G. & Eriksson, E. M., 1 Aug 2018, In : PLoS One. 13, 8, e0202408.

Research output: Contribution to journalArticle

Open Access
Energy Transfer
energy transfer

Projects 2005 2022